Connect with us

Health

Merck says study shows COVID-19 drug causes quick reduction in virus – Reuters

U.S. drugmaker Merck & Co Inc said on Saturday the experimental antiviral drug molnupiravir it is developing with Ridgeback Bio showed a quicker reduction in infectious…

Published

on

Article feature image
ADVERTISEMENT

By Reuters Staff
FILE PHOTO: The Merck logo is seen at a gate to the Merck & Co campus in Rahway, New Jersey, U.S., July 12, 2018. REUTERS/Brendan McDermid
(Reuters) – U.S. drugmaker Merck & Co Inc said on Saturday the experimental antiviral drug molnupiravir it is developing with Ridgeback Bio showed a quicker reduction in infectious virus in its phase 2a study among participants with early COVID-19.
The secondary objective findings in this study, of a quicker decrease in infectious virus among…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Article feature image
Brazil’s hospitals running out of sedatives as COVID-19 rages – Reuters
Article feature image
Coronavirus in Oregon: 733 cases, 6 deaths, 44,971 vaccines administered – OregonLive
Article feature image
Ohio health officials are monitoring review of death of college student who received Johnson & Johnson vaccin – cleveland.com